Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes

Research results show that poor glycemic control and recurrent episodes of severe hypoglycaemia are associated with a decrease in cognitive function in elderly people with type 2 diabetes mellitus (T2DM). On the other hand, patients with diabetes mellitus associated with cognitive impairment/dementi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Olga D. Ostroumova, Elena V. Surkova, Irina V. Goloborodova, Antonina V. Starodubova, Alexey I. Kochetkov, Tamara D. Kiknadze, Gagik R. Galstyan
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2020
Materias:
Acceso en línea:https://doaj.org/article/34b4b191a1704fb8b99d7c5aae6cc87f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:34b4b191a1704fb8b99d7c5aae6cc87f
record_format dspace
spelling oai:doaj.org-article:34b4b191a1704fb8b99d7c5aae6cc87f2021-11-14T09:00:23ZHypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes2072-03512072-037810.14341/DM10202https://doaj.org/article/34b4b191a1704fb8b99d7c5aae6cc87f2020-04-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/10202https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Research results show that poor glycemic control and recurrent episodes of severe hypoglycaemia are associated with a decrease in cognitive function in elderly people with type 2 diabetes mellitus (T2DM). On the other hand, patients with diabetes mellitus associated with cognitive impairment/dementia are most at risk of developing hypoglycaemic conditions. It is obvious that the relationship between hypoglycaemia and dementia is very complex and has a mutually aggravating nature. Studies also show that individuals of older age groups with diabetes and cognitive impairment have a high risk of developing hypoglycaemic conditions, such as unwanted side effects from glucose-lowering therapy. In this case, of particular interest is the question that is being actively studied at the present time, which is concerning the effect of different groups of glucose-lowering antidiabetic drugs on the cognitive status and the rate of cognitive decline in diabetic patients with cognitive impairment. In this review, we attempted to summarise, systematise, and present data available in the literature concerning the effect of hypoglycaemia on the risk of cognitive impairment and dementia in elderly and senile patients with type-2 diabetes, as well as the degree of participation in this process of of various groups of sugar-lowering antidiabetic drugs.Olga D. OstroumovaElena V. SurkovaIrina V. GoloborodovaAntonina V. StarodubovaAlexey I. KochetkovTamara D. KiknadzeGagik R. GalstyanEndocrinology Research Centrearticlehypoglycemiacognitive impairmentdementiadiabetes mellitusantidiabetic drugsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 23, Iss 1, Pp 72-87 (2020)
institution DOAJ
collection DOAJ
language EN
RU
topic hypoglycemia
cognitive impairment
dementia
diabetes mellitus
antidiabetic drugs
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle hypoglycemia
cognitive impairment
dementia
diabetes mellitus
antidiabetic drugs
Nutritional diseases. Deficiency diseases
RC620-627
Olga D. Ostroumova
Elena V. Surkova
Irina V. Goloborodova
Antonina V. Starodubova
Alexey I. Kochetkov
Tamara D. Kiknadze
Gagik R. Galstyan
Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
description Research results show that poor glycemic control and recurrent episodes of severe hypoglycaemia are associated with a decrease in cognitive function in elderly people with type 2 diabetes mellitus (T2DM). On the other hand, patients with diabetes mellitus associated with cognitive impairment/dementia are most at risk of developing hypoglycaemic conditions. It is obvious that the relationship between hypoglycaemia and dementia is very complex and has a mutually aggravating nature. Studies also show that individuals of older age groups with diabetes and cognitive impairment have a high risk of developing hypoglycaemic conditions, such as unwanted side effects from glucose-lowering therapy. In this case, of particular interest is the question that is being actively studied at the present time, which is concerning the effect of different groups of glucose-lowering antidiabetic drugs on the cognitive status and the rate of cognitive decline in diabetic patients with cognitive impairment. In this review, we attempted to summarise, systematise, and present data available in the literature concerning the effect of hypoglycaemia on the risk of cognitive impairment and dementia in elderly and senile patients with type-2 diabetes, as well as the degree of participation in this process of of various groups of sugar-lowering antidiabetic drugs.
format article
author Olga D. Ostroumova
Elena V. Surkova
Irina V. Goloborodova
Antonina V. Starodubova
Alexey I. Kochetkov
Tamara D. Kiknadze
Gagik R. Galstyan
author_facet Olga D. Ostroumova
Elena V. Surkova
Irina V. Goloborodova
Antonina V. Starodubova
Alexey I. Kochetkov
Tamara D. Kiknadze
Gagik R. Galstyan
author_sort Olga D. Ostroumova
title Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
title_short Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
title_full Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
title_fullStr Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
title_full_unstemmed Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
title_sort hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
publisher Endocrinology Research Centre
publishDate 2020
url https://doaj.org/article/34b4b191a1704fb8b99d7c5aae6cc87f
work_keys_str_mv AT olgadostroumova hypoglycemiaandtheriskofcognitiveimpairmentanddementiainelderlyandsenilepatientswithtype2diabetes
AT elenavsurkova hypoglycemiaandtheriskofcognitiveimpairmentanddementiainelderlyandsenilepatientswithtype2diabetes
AT irinavgoloborodova hypoglycemiaandtheriskofcognitiveimpairmentanddementiainelderlyandsenilepatientswithtype2diabetes
AT antoninavstarodubova hypoglycemiaandtheriskofcognitiveimpairmentanddementiainelderlyandsenilepatientswithtype2diabetes
AT alexeyikochetkov hypoglycemiaandtheriskofcognitiveimpairmentanddementiainelderlyandsenilepatientswithtype2diabetes
AT tamaradkiknadze hypoglycemiaandtheriskofcognitiveimpairmentanddementiainelderlyandsenilepatientswithtype2diabetes
AT gagikrgalstyan hypoglycemiaandtheriskofcognitiveimpairmentanddementiainelderlyandsenilepatientswithtype2diabetes
_version_ 1718429458128437248